Arch Suicide Res. 2021 Oct-Dec;25(4):765-789. doi: 10.1080/13811118.2020.1749742. Epub 2020 Apr 10.
This randomized controlled trial compared the Collaborative Assessment and Management of Suicidality (CAMS) and Treatment as Usual (TAU) for suicidal college students within a feasibility trial. Sixty-two suicidal college students were randomized to CAMS ( = 33) or TAU ( = 29). We hypothesized that those receiving CAMS would show more improvement in suicide-related measures, and effects would be moderated by borderline personality disorder (BPD), prior suicide attempts, and age. Both treatment groups showed improvements in all outcome variables; CAMS had a significantly higher impact on depression and suicidal ideation when measured weekly during care and was more likely than TAU to decrease hopelessness among students with fewer BPD features, no suicide attempt history, and older age. Conversely, TAU did better for students with BPD features and history of multiple suicide attempts.
这项随机对照试验比较了协作评估和自杀管理(CAMS)与常规治疗(TAU)对自杀大学生的效果,该研究在可行性试验中进行。62 名有自杀倾向的大学生被随机分配到 CAMS(n=33)或 TAU(n=29)组。我们假设接受 CAMS 的患者在自杀相关指标上会有更大的改善,而这种效果会受到边缘型人格障碍(BPD)、既往自杀企图和年龄的调节。两组治疗均在所有结果变量上都有改善;在治疗过程中每周进行评估时,CAMS 对抑郁和自杀意念的影响明显更大,并且与 TAU 相比,在 BPD 特征较少、无自杀史和年龄较大的学生中,降低绝望感的可能性更高。相反,对于有 BPD 特征和多次自杀企图史的学生,TAU 的效果更好。